RecruitingNot ApplicableNCT06625437

ACT for HIV-Positive Men

Evaluation of the Effectiveness of Acceptance and Commitment Therapy for General Mental Health Concerns in HIV-Positive Men


Sponsor

University of Alabama at Birmingham

Enrollment

24 participants

Start Date

Jan 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a therapy called Acceptance and Commitment Therapy (ACT) — a type of talk therapy that helps people relate differently to difficult thoughts and feelings — in men living with HIV. The goal is to improve mental health and emotional well-being in this group. **You may be eligible if...** - You identify as a man - You are at least 18 years old - You have been diagnosed with HIV by a healthcare provider **You may NOT be eligible if...** - You have engaged in self-harm in the past 3 months - You attempted suicide in the past year - You have had an active suicide plan in the past 30 days - You currently have an eating disorder - You have experienced hallucinations or delusions in the past 30 days - You have used hard drugs (heroin, meth, crack cocaine, opioids) in the past 7 days Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAcceptance and commitment therapy

Acceptance and commitment therapy is a psychotherapy focused at increasing psychological flexibility and an individual\'s engagement in valued activities rather than focusing solely or primarily on reducing psychiatric symptoms


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06625437


Related Trials